ReviewStem cell reviews and reports2026
The Potentials of Stem Cell-Derived Exosomal MicroRNAs in Ferroptosis Modulation: Molecular Insights into Hepatoprotection, Neuroprotection, Cardioprotection, Renoprotection and Pulmonoprotection.
Review in Stem cell reviews and reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ferroptosis is an iron-dependent, regulated form of cell death characterized by lipid peroxidation and disrupted redox homeostasis. This process plays a role in the development of various organ injuries. Stem cell-derived exosomes carrying microRNAs (miRNAs) have recently emerged as a promising therapeutic approach for modulating ferroptosis and providing organ protection. This review summarizes the core molecular mechanisms of ferroptosis, including iron metabolism, lipid peroxidation, the glutathione/GPX4 axis, and regulatory networks involving non-coding RNAs. The biological hallmarks of stem cells, particularly mesenchymal stem cells (MSCs), neural stem cells (NSCs), and induced pluripotent stem cell derivatives (iPSCs), as well as the biogenesis and cargo sorting of exosomal miRNAs, are outlined. Evidence comprehensively shows that stem cell-derived exosomal miRNAs can influence ferroptosis. They provide protective effects in the lungs, liver, nervous system, kidneys, and heart. The review highlights how various exosomal miRNAs target ferroptotic regulators such as SLC7A11, GPX4, and ACSL4, as well as upstream signaling pathways. By tackling the current translational barriers, such as improving exosome engineering, increasing miRNA encapsulation efficiency, ensuring organ-specific delivery, enhancing biosafety, and conducting thorough in vivo validation, stem cell-derived exosomal miRNAs could become a clinically useful and reliable method for precise ferroptosis modulation and multi-organ protection.
Indexed as
Identifiers
42010206What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.